Feasibility Study SA of the Supira System for HRPCI

NARecruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Heart DiseasesCoronary Artery Disease (CAD)Heart Failure
Interventions
DEVICE

Supira System

The Supira System is a temporary (≤ 4 hours) ventricular support device indicated for use during elective or urgent high-risk percutaneous coronary interventions (HRPCI) performed in hemodynamically stable patients with severe coronary artery disease when a heart team has determined HRPCI is the appropriate therapeutic option.

Trial Locations (2)

04012-909

RECRUITING

Instituto Dante Pazzanese De Cardiologia (Dante), São Paulo

5403-000

RECRUITING

'Instituto Do Coração de São Paulo (InCor)', São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Supira Medical

INDUSTRY

NCT05864248 - Feasibility Study SA of the Supira System for HRPCI | Biotech Hunter | Biotech Hunter